3-(methylthio)-1-(3-(thiophen-2-yl)-1,2,4-oxadiazol-5-yl)propan-1-amine oxalate, 95.0%, 1g

5-Bromo-2-mercaptobenzothiazole, 95.0%, 1g

tert-Butyl (1-(3-(hydroxymethyl)phenyl)ethyl)carbamate, 95.0%, 100mg

(S)-1-(2-Amino-ethyl)-pyrrolidin-3-ol, 95.0%, 250mg

tert-Butyl (3S,5R)-3-amino-5-fluoropiperidine-1-carboxylate, 98%, 250mg

2-Fluoro-5-iodo-aniline, 98.0%, 5g

(S)-3-((Acetamidomethyl)thio)-2-((tert-butoxycarbonyl)amino)propanoic acid, 95.0%, 1g

4-Amino-1-methyl-1 H -pyrazole-3-carboxylic acid methyl ester, 95.0%, 10g

5,7-Dibromobenzo[d]thiazole, 97%, 250mg

1-Boc-4-(Methoxy-methyl-carbamoyl)-piperidine, 98.0%, 25g

Sacchetto per omogeneizzazione, 400 ml, 180 mm, Altezza, 300 mm, 500 Pezzo(i)

2-hydrazino-1-(3-methylbutyl)-1H-benzimidazole hydrochloride hydrate, 95.0%, 5g

(R,E)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid, 97.0%, 5g